Table 2 Characteristics of included studies in the meta-analysis analyzing the effect of the CD14 polymorphism on incidence of sepsis
Study | SNP | Sepsis Group (n) | Control Group (n) | Distribution of alleles | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CC | CT | TT | CC | CT | TT | Sepsis Group | Control Group | ||||
C | T | C | T | ||||||||
Bronkhorst, 2013 [33] | CD14-159C/T | 22 | 37 | 20 | 37 | 68 | 35 | 81 | 77 | 142 | 138 |
Dong, 2009 [34] | CD14-159C/T | 3 | 38 | 15 | 4 | 11 | 6 | 44 | 68 | 19 | 23 |
Dong, 2010 [35] | CD14-159C/T | 3 | 9 | 7 | 4 | 7 | 5 | 15 | 23 | 15 | 17 |
Gibot, 2002 [22] | CD14-159C/T | 19 | 43 | 28 | 44 | 52 | 26 | 81 | 99 | 140 | 104 |
Gu, 2008 [29] | CD14-159C/T | 5 | 23 | 14 | 16 | 35 | 12 | 33 | 51 | 67 | 59 |
Lin, 2004 [32] | CD14-159C/T | 0 | 4 | 3 | 2 | 6 | 1 | 4 | 10 | 10 | 8 |
Nakada, 2005 [40] | CD14-159C/T | 15 | 43 | 28 | 27 | 42 | 42 | 73 | 99 | 96 | 126 |
D’Avila, 2006 [30] | CD14-159C/T | 17 | 19 | 16 | 10 | 16 | 7 | 53 | 51 | 36 | 30 |
Fallavena, 2009 [16] | CD14-159C/T | 108 | 172 | 63 | 49 | 78 | 44 | 388 | 298 | 176 | 166 |
Heesen, 2002 [25] | CD14-159C/T | 5 | 5 | 4 | 15 | 22 | 7 | 15 | 13 | 52 | 36 |